IFNG and COVID-19: Among the 19 patients who experienced COVID-19 during the vaccine cycle, 5 (26.3%) were not responders at the humoral level (i.e., they did not develop IgG), while only one patient did not respond at the cellular level (i.e., he did not develop an IFNγ response).